Interestingly, GAP-43, Ng, and SNAP-25 were increased in CSF and decreased in exosomes isolated from the blood of AD and MCI patients, suggesting a role for such exosomal biomarkers in distinguishing AD from MCI patients and in predicting AD 5 to 7 years before cognitive deterioration [99]. This evidence concerns the gene NRGN and Alzheimer disease.